Sec. 2. (a) Subject to subsection (d), every infant shall be given examinations at the earliest feasible time for the detection of the following disorders:

(1) Phenylketonuria.

(2) Hypothyroidism.

(3) Hemoglobinopathies, including sickle cell anemia.

(4) Galactosemia.

(5) Maple Syrup urine disease.

(6) Homocystinuria.

(7) Inborn errors of metabolism that result in an intellectual disability and that are designated by the state department.

(8) Congenital adrenal hyperplasia.

(9) Biotinidase deficiency.

(10) Disorders detected by tandem mass spectrometry or other technologies with the same or greater detection capabilities as tandem mass spectrometry, if the state department determines that the technology is available for use by a designated laboratory under section 7 of this chapter.

(11) Spinal muscular atrophy.

(12) Severe combined immunodeficiency.

(13) Beginning July 1, 2020, Krabbe disease.

(14) Beginning July 1, 2020, Pompe disease.

(15) Beginning July 1, 2020, Hurler syndrome (MPS1).

(16) Adrenoleukodystrophy (ALD).

(17) Beginning July 1, 2022, and in addition to the disorders listed in subdivisions (1) through (16), only a disorder recommended by a perinatal genetics and genomics advisory committee with expertise in newborn screening and through protocols prescribed by the state department.

Beginning July 1, 2022, a perinatal genetics and genomics advisory committee with expertise in newborn screening, and through protocols established by the state department, may recommend the addition of a disorder to, or deletion of a disorder from, the required examination under this subsection. The state department shall adopt rules under IC 4-22-2 to add disorders to, or delete disorders from, the required examination under this subsection. The state department shall include any disorder added to or deleted from the required examination on a list on the state department’s Internet web site. The perinatal genetics and genomics advisory committee shall affirm the addition of, or deletion of, any disorder to the examination requirement on an annual basis.

     (b) Subject to subsection (d), every infant shall be given a physiologic hearing screening examination at the earliest feasible time for the detection of hearing impairments.

     (c) Subject to subsection (d), every infant shall be given a pulse oximetry screening examination in accordance with rules adopted by the state department for the detection of low oxygen levels. Section 10(a)(2) of this chapter does not apply to this subsection.

     (d) If a parent of an infant objects in writing, for reasons pertaining to religious beliefs only, the infant is exempt from the examinations required by this chapter.

[Pre-1993 Recodification Citation: 16-8-6-1.]

As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.2; P.L.149-2001, SEC.3; P.L.229-2011, SEC.165; P.L.117-2015, SEC.34; P.L.17-2018, SEC.1; P.L.1-2019, SEC.1; P.L.19-2020, SEC.1; P.L.77-2022, SEC.1.